Thomas B. Smith - Feb 10, 2023 Form 4 Insider Report for COLLEGIUM PHARMACEUTICAL, INC (COLL)

Signature
/s/ Colleen Tupper as Attorney-In-Fact For Thomas B. Smith, MD
Stock symbol
COLL
Transactions as of
Feb 10, 2023
Transactions value $
$0
Form type
4
Date filed
2/14/2023, 04:19 PM
Previous filing
Apr 1, 2022
Next filing
Feb 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COLL Common Stock Award $0 +31.2K $0.00 31.2K Feb 10, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2024, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.